FDA expands clearance for Barco’s Coronis Uniti display

The FDA has cleared the Coronis Uniti diagnostic display from Barco for use with breast MRI, CT, breast ultrasound and other ultrasound indications, including vascular and gynecological ultrasound.

The display had previously been approved for viewing PACS and mammography, including tomosynthesis. The new indications approved by the FDA make the Coronis Uniti the first diagnostic display cleared for viewing all types of breast imaging exams, according to the company.

Radiologists can now run side-by-side comparisons and image fusions during interpretation, combining ultrasound with conventional mammography, for example. Barco said it developed proprietary technology to automatically set color and grayscale settings based on modality, even when multiple types of exams appear onscreen simultaneously. 

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.